Cinctive Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Other funds holding SRPT
Cinctive Capital Management's SRPT Position: Q3 2026 in Review
Cinctive Capital Management sold out of Sarepta Therapeutics (SRPT) in Q3 2026, closing a stake of 48,855 shares — an estimated $878K sold.
Cinctive Capital Management first reported a position in SRPT in Q4 2021 and held it in 4 quarters. The position peaked at $10.1M in Q1 2024. 256 funds tracked by Wall St. Rank hold SRPT as of Q3 2026.
- Cinctive Capital Management reported no remaining Sarepta Therapeutics position as of Q3 2026 after selling out during the quarter.
- Cinctive Capital Management sold 48,855 Sarepta Therapeutics shares in Q3 2026, an estimated $878K.
- Cinctive Capital Management first reported a position in Sarepta Therapeutics in Q4 2021 and held it in 4 quarters.
- Cinctive Capital Management's Sarepta Therapeutics position peaked at $10.1M in Q1 2024.
- 256 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2026.
Based on Cinctive Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.